111, Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. Through the T2B2C business model, by leveraging technology to enable businesses better serve customers, 111, Inc. is devoted to digitally connecting patients with drugs and healthcare services, to build the largest healthcare platform in China.
Relying on advantages in Internet technology, smart supply chain, omni-channel commercialization, cloud-based solutions, and other aspects, 111, Inc. integrates online and offline retail platforms and terminals, establishes a healthcare ecosystem, and empowers doctors, pharmacies, hospitals, pharmaceutical companies, drug distributors, insurance companies and other enterprises. 111, Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people.
The main business lines of 111, Inc. include: 1 Drugstore (online B2C pharmacy platform), 1 Clinic (Internet hospital) and 1 Drug Mall (online B2B pharmacy platform). Through innovative technology-enabled models, fully realizing the integrated development of B and C, online and offline, self-operating and platform, and medical + pharmaceutical + insurance. On September 12, 2018, 111, Inc. was listed on NASDAQ with ticker YI. It is the first Internet health company from China listed in the US stock exchange.
Location of Key Operations
Deloitte Touche Tohmatsu CPA LLP
IPO (September 12, 2018)
6 Fulfillment Centers: Guangzhou, Kunshan, Tianjin, Chongqing, Wuhan, Fuzhou)
September 7, 2021: 111, Inc. Announces $10 Million Share Repurchase Program
August 16, 2021: 111, Inc. Deepens Partnership with Bayer Healthcare - Aug 16, 2021
March 18, 2021: 111 Inc (YI) Q4 2020 Earnings Call Transcript